Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases
Servier backs American startup’s research project at LabCentral
HiFiBiO Therapeutics Secures $37.5 Million Series B Financing to Accelerate Pipeline of Novel Antibody Drugs to Treat Cancer and Autoimmune Disorders
ReviveMed turns drug discovery into a big data problem and raises $1.5 M to solve it
Kronos Bio Appoints Dr. Norbert Bischofberger, Former Head of R&D for Gilead Sciences, as President and Chief Executive Officer and Completes $18 Million Seed Financing
Pfizer Opens Call for Proposals for Neuroscience Start-ups to Apply for LabCentral Residency
Pfizer Opens Call for Proposals for Start-ups to Apply for LabCentral Residency
Pfizer Opens a Call For Proposals For LabCentral Residency
